Skip to main content
. 2023 Nov 28;12(12):1395. doi: 10.3390/pathogens12121395

Table 4.

Association between LST and ACL scar status at the time of survey of the human study population and reported period of residence at the time of ACL lesion appearance.

Infection Status (n) Median (Q1, Q3) Period of Residential Exposure in Years Prior to Appearance of ACL Active Lesion
LST+ve scar+ve (158) 20 (8.0, 60.0)
LST+ve scar-ve (71) 15 (2.0, 57.0)
LST-ve scar+ve (8) 16 (6.0, 55.0)
LST-ve scar-ve (266) 13 (2.0, 54.7)